France Eubiotics Market Size, Share, and COVID-19 Impact Analysis, By Form (Liquid, Solid), By Product (Probiotics, Prebiotics, and Organic Acids), and France Eubiotics Market Insights, Industry Trend, Forecasts to 2035
Industry: HealthcareFrance Eubiotics Market Insights Forecasts to 2035
- The France Eubiotics Market Size was Estimated at USD 728.4 Million in 2024
- The Market Size is Expected to Grow at a CAGR of around 6.97% from 2025 to 2035
- The France Eubiotics Market Size is Expected to Reach USD 1528.6 Million by 2035
Get more details on this report -
According to a research report published by Spherical Insights and Consulting, The France Eubiotics Market Size is anticipated to reach USD 1528.6 Million by 2035, growing at a CAGR of 6.97% from 2025 to 2035. This is due to one of the positive regulatory environments that forbid the use of antibiotics, and rising meat consumption is expected to fuel demand for the product. There is fierce competition in the market, with long-standing, established companies holding a significant portion of the market.
Market Overview
The France eubiotics market is the market that concentrates on feed additives with the goal of promoting gut health in animals to improve animal performance and welfare. The term eubiotic, coming from the eubiosis, which is defined by the FAO as appropriate, healthy gut microbiota, will reference a variety of unique products, including prebiotics, probiotics, organic acids, and essential oils. Eubiotics are viewed as an option to using antibiotics in animal feed and will address concerns of antibiotic resistance while not leaving sustainable options out of the equation. It is expected that a positive regulatory environment banning the use of antibiotics, together with an increase in meat consumption around the nation, will drive the demand for the product. The market has a high level of competition with incumbents and established players having the majority of market share due to prolonged operational presence. Companies continue to make substantial investments in R&D projects focused on innovation to implement sustainable technologies to create affordable and cost-effective products.
Report Coverage
This research report categorizes the market for the France eubiotics market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the France eubiotics market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the France eubiotics market.
France Eubiotics Market Report Coverage
Report Coverage | Details |
---|---|
Base Year: | 2024 |
Market Size in 2024: | USD 728.4 Million |
Forecast Period: | 2025-2035 |
Forecast Period CAGR 2025-2035 : | CAGR Of 6.97% |
2035 Value Projection: | USD 1528.6 Million |
Historical Data for: | 2020-2023 |
No. of Pages: | 261 |
Tables, Charts & Figures: | 103 |
Segments covered: | By Form and By Product |
Companies covered:: | DSM, Novus International, Inc., Calpis Co., Ltd., UAS Laboratories, BEHN MEYER, Novozymes, Lesaffre Group, Chr. Hansen Holding A/S, Kemin Industries, Inc., Lallemand, Inc., BENEO, and Others |
Pitfalls & Challenges: | COVID-19 Empact, Challenges, Future, Growth, & Analysis |
Get more details on this report -
Driving Factors
The France eubiotics market is mainly driven by a growing awareness of gut health in livestock, growing demand for natural and sustainable food production, and bans on antibiotic growth promoters (AGPs) in animal feed. As such, there is an increasing displacement of AGPs with eubiotics to promote animal health, improve feed efficiency, and produce quality meat and dairy products. Eubiotics are produced products, either through feed mills, pre-mixers, or some distributors. The eubiotic manufacturers sell their products directly to their customers or sell to integrated feed producers. In both cases where eubiotic products were delivered, these reached the livestock producers.
Restraining Factors
The France eubiotics market has a number of significant challenges, most notably high production costs, price volatility in raw materials, and regulatory barriers. In addition, other issues could impede growth, such as limited awareness of eubiotics in particular developing markets, and the risk of disease outbreaks in livestock.
Market Segmentation
The France Eubiotics Market share is classified into form and product.
- The solid segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period.
The France eubiotics market is segmented by form into liquid and solid. Among these, the solid segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period. Its benefits, such as improved defense against light and moisture exposure, are responsible for this high share. Flakes, beadlets, and cross-linked beadlets are examples of solid forms. In feed production, beadlet technology consistently shields the active ingredients from heat and mechanical stress, increasing their stability and bioavailability.
- The probiotics segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.
The France eubiotics market is segmented by product into probiotics, prebiotics, and organic acids. Among these, the probiotics segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is explained by growing consumer awareness of the use of probiotics in animal feed, continuous research and development efforts to create effective products, and a wide range of products offered by significant industry players. Additionally, the market demand is anticipated to benefit from the numerous applications in animal applications, such as immunity development and gut health maintenance.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the France eubiotics market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Key Companies
- DSM
- Novus International, Inc.
- Calpis Co., Ltd.
- UAS Laboratories
- BEHN MEYER
- Novozymes
- Lesaffre Group
- Chr. Hansen Holding A/S
- Kemin Industries, Inc.
- Lallemand, Inc.
- BENEO
- Others
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at the global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the France Eubiotics Market based on the below-mentioned segments:
France Eubiotics Market, By Form
- Liquid
- Solid
France Eubiotics Market, By Product
- Probiotics
- Prebiotics
- Organic Acids
Need help to buy this report?